Dimethylarginine: Biomarkers in progression of kidney disease

Dimethylarginine: Biomarkers in progression of kidney disease

Decreased nitric oxide (NO) production and/or impaired NO bioavailability may occur in patients with the chronic kidney disease (CKD), and could contribute to elevation of blood pressure, cardiovascular disease (CVD) and progression of renal injury in these patients. Free guanidinomethylated arginin...

Full description

Bibliographic Details
Main Authors:	Cvetković Tatjana, Pavlović Radmila, Đorđević Vidosava, Stojanović Ivana, Veličković-Radovanović Radmila, Ignjatović Aleksandra, Stefanović Nikola, Živanović Slavoljub, Đorđević Vidojko
Format:	Article
Language:	English
Published:	Society of Medical Biochemists of Serbia, Belgrade 2012-01-01
Series:	Journal of Medical Biochemistry
Subjects:	nitric oxide (no) asymmetric dimethyl arginine(adma) kidney disease endothelial dysfunction
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2012/1452-82581204301C.pdf

Similar Items

Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE)
by: Juliane Hannemann, et al.
Published: (2023-11-01)

Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients
by: Rajni Rajendra Shivkar, et al.
Published: (2014-08-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
by: Cvetković Tatjana, et al.
Published: (2015-01-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea
by: Juliane Hannemann, et al.
Published: (2023-08-01)

Inhibitory effect of asymmetric dimethylarginine and NG-Monomethyl-L-arginine methyl ester on nitric oxide synthase activity
by: Kadkhodaei Elyaderani M, et al.
Published: (2013-09-01)

L-Arginine-Nitric Oxide-Asymmetric Dimethylarginine Pathway and the Coronary Circulation: Translation of Basic Science Results to Clinical Practice
by: Attila Cziráki, et al.
Published: (2020-09-01)

Asymmetric dimethylarginine in adult falciparum malaria: relationships with disease severity, antimalarial treatment, hemolysis, and inflammation
by: Barber, Bridget E., et al.
Published: (2018)

Serum concentration of Apelin and Asymmetric Dimethylarginine in hypertensive patients on different modalities of treatment
by: Faisal Gh. Al-Rubaye
Published: (2013-02-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021-08-01)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
by: Carlotta Valente, et al.
Published: (2021-09-01)

L-Arginine Supplementation and Metabolism in Asthma
by: Angela Linderholm, et al.
Published: (2011-01-01)

Overexpression of Dimethylarginine Dimethylaminohydrolase Enhances Tumor Hypoxia: An Insight into the Relationship of Hypoxia and Angiogenesis In Vivo
by: Vassiliki Kostourou, et al.
Published: (2004-07-01)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
by: Tzong-Shyuan Lee, et al.
Published: (2021-10-01)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
by: Tan C, et al.
Published: (2021-12-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
by: Yanzhe Wang, et al.
Published: (2022-09-01)

Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats
by: Kamaldeep Kaur, et al.
Published: (2019-12-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke—A Dynamic Human LC/MS Metabolomic Study
by: Maciej Bladowski, et al.
Published: (2022-05-01)

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
by: Julie-Ann Hulin, et al.
Published: (2020-01-01)

Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
by: Juliane Hannemann, et al.
Published: (2020-04-01)

L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure
by: Anna Drohomirecka, et al.
Published: (2023-02-01)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
by: Zhi-min Yu, et al.
Published: (2019-01-01)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
by: Chiara Volani, et al.
Published: (2021-03-01)

Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude
by: Patricia Siques, et al.
Published: (2019-05-01)

Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y+LAT2 Carrier-Mediated Loss
by: Krzysztof Milewski, et al.
Published: (2017-11-01)

Arginine metabolomics in mood disorders
by: Angelo Zinellu, et al.
Published: (2024-03-01)

Metabolites of L-ARG in Exhaled Breath Condensate and Serum Are Not Biomarkers of Bronchial Asthma in Children
by: Joanna Połomska, et al.
Published: (2022-01-01)

Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
by: Müfide Arzu Özkarafakılı, et al.
Published: (2022-06-01)

Effect of profilin‐1 on the asymmetric dimethylarginine‐induced vascular lesion‐associated hypertension
by: Guo‐Hua Ni, et al.
Published: (2022-02-01)

Nitric oxide: Mediated signalization and nitrosative stress in neuropathology
by: Stojanović Ivana, et al.
Published: (2012-01-01)

Combined Citrulline and Glutathione Supplementation Improves Endothelial Function and Blood Pressure Reactivity in Postmenopausal Women
by: Arturo Figueroa, et al.
Published: (2023-03-01)

Circulating Concentrations of Key Regulators of Nitric Oxide Production in Undernourished Sheep Carrying Single and Multiple Fetuses
by: Fiammetta Berlinguer, et al.
Published: (2019-12-01)

Cardiovascular Disorders Triggered by Obstructive Sleep Apnea—A Focus on Endothelium and Blood Components
by: Jakub Mochol, et al.
Published: (2021-05-01)

Current biochemical monitoring and risk management of immunosuppressive therapy after transplantation
by: Catić-Đorđević Aleksandra, et al.
Published: (2017-01-01)

CARVEDILOL POPULATION PHARMACOKINETIC ANALYSIS – APPLIED VALIDATION PROCEDURE
by: Aleksandra Catić-Đorđević, et al.
Published: (2013-09-01)

Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
by: Christoffer Nyborg, et al.
Published: (2021-08-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)